Jean-Jacques Bienaime

Shares of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) have witnessed a spectacular rise in the last year, up by more than 67 percent. What's causing this rally? Jean-Jacques Bienaime, BioMarin Pharmaceuticals CEO, was on CNBC Monday to answer that question and to discuss the new drugs that...